What’s been published/presented?

Click on the links below or to the right for category to view publications of interest to you. You can also search our publications database by author, keyword(s), date of publication, journal or other parameters.

Molecular profiling of breast cancer: clinical implications
Publication Name: British Journal of Cancer (2004) 90, 1120 – 1124
Date: 01-01-2004
Author(s): S Cleator and A Ashworth
Abstract or Overview: Breast cancers are routinely subcategorised on the basis of clinical stage, cellular morphology and immunohistochemical analysis of a small number of markers.
Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer
Publication Name: Cancer Res 2005
Date: 01-01-2005
Author(s): Britta Weigelt, Zhiyuan Hu, Xiaping He, Chad Livasy, Lisa A. Carey
Abstract or Overview: Microarray analysis has been shown to improve risk stratification of breast cancer. Breast tumors analyzed by hierarchical clustering of expression patterns of "intrinsic" genes have been reported to subdivide into at least four molecular subtypes that are associated with distinct patient outcomes.
Concordance among Gene-Expression– Based Predictors for Breast Cancer
Publication Name: The New England Journal o f Medicine
Date: 01-01-2006
Author(s): Cheng Fan, M.S., Daniel S. Oh, Ph.D., Lodewyk Wessels, Ph.D., Britta Weigelt, Ph.D., Dimitry S.A. Nuyten, M.D., Andrew B. Nobel, Ph.D., Laura J. van’t Veer, Ph.D., and Charles M. Perou, Ph.D.
Abstract or Overview: Gene expression profiling studies of primary breast tumors performed by different laboratories have resulted in the identification of a number of distinct prognostic profiles, or gene sets, with little overlap in terms of gene identity.
On the Toxicity of Chemotherapy for Breast Cancer — the Need for Vigilance
Publication Name: Journal of the National Cancer Institute,
Date: 01-01-2006
Author(s): John K. Erban , Joseph Lau
Abstract or Overview: A study published in The Journal of the National Cancer Institute, found that advanced chemotherapy put patients at far greater risks of harm than adverse effect reports from clinical trial data reveal.
Frequency and cost of chemotherapy - related serious adverse effects in a population sample of women with breast cancer.
Date: 01-01-2006
Abstract or Overview: Background: The number, nature, and costs of serious adverse effects experienced by younger women receiving chemotherapy for breast cancer outside of clinical trials are unknown.


View More
 Filter by Topic Areas
  Back To Top
 

The publication has been added to your order.